SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000831547-23-000003
Filing Date
2023-03-22
Accepted
2023-03-22 14:44:53
Documents
14
Period of Report
2023-03-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sppi-20230322.htm   iXBRL 8-K 28565
2 EX-99.1 exhibit991q42022.htm EX-99.1 127293
6 thumbnail_cleara.jpg GRAPHIC 11800
  Complete submission text file 0000831547-23-000003.txt   318156

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sppi-20230322.xsd EX-101.SCH 1909
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sppi-20230322_lab.xml EX-101.LAB 25149
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sppi-20230322_pre.xml EX-101.PRE 13054
8 EXTRACTED XBRL INSTANCE DOCUMENT sppi-20230322_htm.xml XML 4287
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filer) CIK: 0000831547 (see all company filings)

IRS No.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35006 | Film No.: 23752662
SIC: 2834 Pharmaceutical Preparations